SRC signaling was active in both the eutopic endometrium of endometriosis patients and in in vitro models of endometriosis, and their findings suggested the novel therapeutic potential of Src inhibition (Src-pY416) for treating endometriosis-associated ovarian cancers (EAOCs) (97). Here, SRC is linked to ovarian cancer.